See more : Kansai Paint Co., Ltd. (KSANF) Income Statement Analysis – Financial Results
Complete financial analysis of Stem Holdings, Inc. (STMH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Stem Holdings, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- US Nuclear Corp. (UCLE) Income Statement Analysis – Financial Results
- Cortland Bancorp (CLDB) Income Statement Analysis – Financial Results
- Domino’s Pizza Enterprises Limited (DPZUF) Income Statement Analysis – Financial Results
- SDS HOLDINGS Co.,Ltd. (1711.T) Income Statement Analysis – Financial Results
- KULR Technology Group, Inc. (KULR) Income Statement Analysis – Financial Results
Stem Holdings, Inc. (STMH)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://stemholdings.com
About Stem Holdings, Inc.
Stem Holdings, Inc. operates as a vertically-integrated cannabis products and technology company. It engages in the production, distribution, and sale of cannabis and cannabis-infused products. The company's brands include TJ's Gardens, TravisxJames, and Yerba Buena flower and extracts; Cannavore edible confections; Doseology, a CBD mass-market brand; and delivery-as-a-service brands of Budee and Ganjarunner e-commerce platforms. As of September 30, 2021, it had ownership interests in 29 state issued cannabis licenses, including 9 licenses for cannabis cultivation; 3 licenses for cannabis processing; 2 licenses for cannabis wholesale distribution; 3 licenses for hemp production; 7 cannabis dispensary licenses; and 5 licenses for adult-use medical retailers. The company was incorporated in 2016 and is headquartered in Boca Raton, Florida.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 16.56M | 35.77M | 13.97M | 2.45M | 1.30M | 326.04K | 0.00 |
Cost of Revenue | 0.00 | 14.44M | 28.18M | 10.31M | 1.94M | 7.56M | 0.00 | 0.00 |
Gross Profit | 0.00 | 2.12M | 7.59M | 3.67M | 516.00K | -6.26M | 326.04K | 0.00 |
Gross Profit Ratio | 0.00% | 12.82% | 21.21% | 26.25% | 21.05% | -483.44% | 100.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 3.64M | 14.48M | 22.96M | 13.33M | 19.29M | 8.86M | 2.78M | 87.70K |
Selling & Marketing | 103.00K | 266.00K | 368.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 3.75M | 14.48M | 22.96M | 13.33M | 19.29M | 8.86M | 2.78M | 87.70K |
Other Expenses | 0.00 | 1.97M | 2.30M | 0.00 | -40.00K | 44.39K | 0.00 | 0.00 |
Operating Expenses | 3.75M | 14.48M | 22.96M | 13.33M | 19.29M | 8.86M | 2.78M | 87.70K |
Cost & Expenses | 3.75M | 28.92M | 51.14M | 23.64M | 21.22M | 8.86M | 2.78M | 87.70K |
Interest Income | 0.00 | 650.00K | 1.95M | 2.43M | 2.59M | 440.00 | 5.22K | 0.00 |
Interest Expense | 1.24M | 650.00K | 1.88M | 2.43M | 2.59M | 345.66K | 975.00 | 0.00 |
Depreciation & Amortization | -156.29K | 2.49M | 2.24M | 2.37M | 1.23M | 1.36M | 129.22K | 263.10K |
EBITDA | -3.90M | -7.90M | -2.92M | -6.74M | -25.22M | -7.04M | -2.75M | -87.70K |
EBITDA Ratio | 0.00% | -47.68% | -22.13% | -54.05% | -984.54% | -474.75% | -711.38% | 0.00% |
Operating Income | -3.75M | -12.36M | -15.37M | -9.67M | -18.77M | -7.56M | -2.75M | -87.70K |
Operating Income Ratio | 0.00% | -74.61% | -42.98% | -69.17% | -765.89% | -583.44% | -843.73% | 0.00% |
Total Other Income/Expenses | -1.39M | -10.14M | 3.37M | -1.83M | -6.92M | -301.00K | 4.24K | -175.40K |
Income Before Tax | -5.13M | -16.62M | -64.61M | -11.49M | -28.99M | -7.86M | -2.75M | -87.70K |
Income Before Tax Ratio | 0.00% | -100.32% | -180.62% | -82.25% | -1,182.58% | -606.66% | -842.43% | 0.00% |
Income Tax Expense | 0.00 | 10.78M | 3.71M | 1.69M | -7.69M | 44.83K | 975.00 | -263.10K |
Net Income | -19.02M | -27.40M | -68.32M | -13.18M | -21.30M | -7.86M | -2.75M | -87.70K |
Net Income Ratio | 0.00% | -165.40% | -190.99% | -94.34% | -868.87% | -606.66% | -842.43% | 0.00% |
EPS | -5.92 | -12.11 | -42.88 | -21.92 | -75.40 | -94.64 | -49.07 | -3.27 |
EPS Diluted | -5.92 | -12.11 | -42.88 | -21.92 | -75.40 | -94.64 | -49.07 | -3.27 |
Weighted Avg Shares Out | 2.53M | 2.26M | 1.59M | 601.43K | 282.45K | 83.05K | 55.97K | 26.85K |
Weighted Avg Shares Out (Dil) | 2.53M | 2.26M | 1.59M | 601.43K | 282.45K | 83.05K | 55.97K | 26.85K |
Stem Holdings Announces Delay in Annual Filings and Expected Cease Trade Order
Stem Holdings Announces Approval of Debenture Repricing
SHAREHOLDER ALERT: Kaskela Law LLC Announces Stockholder Investigation of Stem, Inc. (STEM) and Encourages Long-Term STEM Investors to Contact the Firm
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Stem, Inc. f/k/a Star Peak Energy Transition Corp. (STEM)
Stem Holdings Sees Cannabis Earnings Rise, Aims For Positive Adjusted EBITDA in 2022
Budee™ Unveils New Shoppable Cannabis Delivery App for Apple
Driven By Stem Expands California E-Commerce and Delivery Footprint with New Distribution Hub License
Driven By Stem Announces the Acquisition of Artifact Extracts, Salem Delivery Capabilities, and Two Additional Dispensaries
Stem Holdings, Inc. (STMH) CEO Adam Berk on Q3 2021 Results - Earnings Call Transcript
CORRECTION – Stem Holdings, Inc. d/b/a Driven By Stem Announces Record Sales and Gross Margin for the Third Quarter
Source: https://incomestatements.info
Category: Stock Reports